Cargando…

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer

There are limited data on circulating, cell-free, tumour (ct)DNA analysis in locally advanced rectal cancer (LARC). Digital droplet (dd)PCR was used to investigate KRAS/BRAF mutations in ctDNA from baseline blood samples of 97 LARC patients who were treated with CAPOX followed by chemoradiotherapy,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sclafani, Francesco, Chau, Ian, Cunningham, David, Hahne, Jens C., Vlachogiannis, George, Eltahir, Zakaria, Lampis, Andrea, Braconi, Chiara, Kalaitzaki, Eleftheria, De Castro, David Gonzalez, Wotherspoon, Andrew, Capdevila, Jaume, Glimelius, Bengt, Tarazona, Noelia, Begum, Ruwaida, Lote, Hazel, Hulkki Wilson, Sanna, Mentrasti, Giulia, Brown, Gina, Tait, Diana, Oates, Jacqueline, Valeri, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780472/ https://www.ncbi.nlm.nih.gov/pubmed/29362371 http://dx.doi.org/10.1038/s41598-018-19212-5

Ejemplares similares

Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients
por: Sclafani, Francesco, et al.
Publicado: (2016)

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial
por: Sclafani, F., et al.
Publicado: (2015)

Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study
por: Khan, Khurum, et al.
Publicado: (2018)

Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer
por: Sclafani, Francesco, et al.
Publicado: (2017)

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers
por: Smyth, Elizabeth C, et al.
Publicado: (2021)

Molecular profiling of colorectal pulmonary metastases and primary tumours: implications for targeted treatment
por: Moorcraft, Sing Y., et al.
Publicado: (2017)

Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study
por: Turkes, Fiona, et al.
Publicado: (2022)

MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma
por: Lampis, Andrea, et al.
Publicado: (2018)

Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer
por: Lote, H., et al.
Publicado: (2017)

HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer
por: Lote, Hazel, et al.
Publicado: (2018)

Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised study
por: Lau, David, et al.
Publicado: (2020)

miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial
por: Khan, Khurum, et al.
Publicado: (2016)

Vault RNAs: hidden gems in RNA and protein regulation
por: Hahne, Jens Claus, et al.
Publicado: (2020)

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
por: Smyth, Elizabeth C., et al.
Publicado: (2016)

MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma
por: Trevisani, Francesco, et al.
Publicado: (2016)

MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer
por: Lampis, Andrea, et al.
Publicado: (2021)

Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage
por: Carotenuto, Pietro, et al.
Publicado: (2021)

Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches
por: Ratti, Margherita, et al.
Publicado: (2018)

Modulation of Biliary Cancer Chemo‐Resistance Through MicroRNA‐Mediated Rewiring of the Expansion of CD133+ Cells
por: Carotenuto, Pietro, et al.
Publicado: (2020)

Introduction of Sprotte needles to a single-centre acute neurology service: before and after study
por: Vakharia, Vejay N, et al.
Publicado: (2012)

Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes
por: Ragulan, Chanthirika, et al.
Publicado: (2019)

MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside
por: Ratti, Margherita, et al.
Publicado: (2020)

SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)
por: Capdevila, Jaume, et al.
Publicado: (2022)

Correction to: SEOM‑GEMCAD‑TTD clinical guidelines for localized rectal cancer (2021)
por: Capdevila, Jaume, et al.
Publicado: (2022)

Allowing for missing outcome data and incomplete uptake of randomised interventions, with application to an Internet-based alcohol trial
por: White, Ian R, et al.
Publicado: (2011)

Estimating effect of intervention delivery in the evaluation of complex intervention with various levels of compliance
por: Leurent, Baptiste, et al.
Publicado: (2013)

Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer
por: Ghidini, Michele, et al.
Publicado: (2020)

Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review)
por: Lampis, Andrea, et al.
Publicado: (2021)

Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial
por: Fontana, Elisa, et al.
Publicado: (2020)

A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAF(V600) wild-type colorectal cancer
por: Georgiou, Alexandros, et al.
Publicado: (2021)

Adenocarcinoma of the seminal vesicles complicated by antineutrophil cytoplasmic antibody vasculitis: a case report and review of the literature
por: Lote, Hazel, et al.
Publicado: (2013)

Epidermal Growth Factor Mutation as a Diagnostic and Therapeutic Target in Metastatic Poorly Differentiated Thyroid Carcinoma: A Case Report and Review of the Literature
por: Lote, Hazel, et al.
Publicado: (2014)

Characterisation of the immune-related transcriptome in resected biliary tract cancers
por: Ghidini, Michele, et al.
Publicado: (2017)

Characterization of Photoactive Fe-TiO(2) Lime Coatings for Building Protection: The Role of Iron Content
por: Kapridaki, Chrysi, et al.
Publicado: (2019)

Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors
por: Hahne, Jens C., et al.
Publicado: (2018)

Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib
por: Stjepanovic, Neda, et al.
Publicado: (2014)

Diagnostic Accuracy and Safety of Coaxial System in Oncology Patients Treated in a Specialist Cancer Center With Prospective Validation Within Clinical Trial Data
por: Khan, Khurum, et al.
Publicado: (2020)

The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract
por: Formica, V, et al.
Publicado: (2007)

Successful Downstaging of High Rectal and Recto-Sigmoid Cancer by Neo-Adjuvant Chemo-Radiotherapy
por: O’Neill, Brian, et al.
Publicado: (2008)

Chemoradiotherapy response in recurrent rectal cancer
por: Yu, Stanley K T, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vg1kap84a1edtfc56k1944edbi